Dr. Matthew J. Ellis from Washington University on Measuring Endocrine Therapy Efficacy With Ki67
OncLive TV
Dr. Ken Yoneda from the UC Davis Cancer Center Describes the Clinical Care Pulmonologist
Advertisement
Dr. Tianhong Li from UC Davis Cancer Center Discusses the PROFILE Crizotinib Clinical Trials
Dr. Debu Tripathy from the USC Norris Cancer Center on Connecting Markers to Clinical Outcomes
Dr. Giorgio V. Scagliotti from the University of Turin Discusses Personalizing Care With Pemetrexed
Dr. Matthew J. Ellis from Washington University Discusses Ki67 as a Treatment Monitoring Biomarker
Advertisement
Dr. Joyce A. O'Shaughnessy from Baylor Sammons Cancer Center on the Future of Breast Cancer Biomarkers
Dr. Tianhong (Tina) Li from UC Davic Cancer Center Discusses ALK Gene Mutation Tests
Dr. Matthew J. Ellis from Washington University Discusses the Future of the PI3-Kinase Pathway
Dr. Ken Y. Yoneda from UC Davis Cancer Center on Advances in the Diagnosis of Lung Cancer
Dr. Karen Reckamp from the City of Hope Cancer Center Discusses the Use of Hsp90 Inhibitors
Dr. Debu Tripathy from USC Norris Cancer Center on Determining the Best HER2 Targeted Therapy
Dr. Matthew Ellis from Washington University Discusses the Cell-Proliferation Marker Ki67
Dr. Ken Yoneda from UC Davis Cancer Center Discusses Bronchoscopy Tools and Procedures
Dr. Joyce O'Shaughnessy from Baylor Sammons Cancer Center on Negative TNBC Iniparib Trial Results
Dr. Karen Reckamp City of Hope cancer center on Current Heat Shock Protein Clinical Trials
Dr. Debu Tripathy from UC Norris Cancer Center Discusses HER2 Targeted Therapies
Dr. Ken Yoneda from UC Davis Cancer Center Discusses the Role of the Pulmonologist
Dr. Karen Reckamp from City of Hope Cancer Center Describes the Use of Heat Shock Proteins
Dr. Mary J. C. Hendrix from Northwestern University's Feinberg School of Medicine on Metastatic Tumor Cells in Microenvironments
Dr. Debu Tripathy from USC Norris Cancer Center on Completing New Assays After Recurrence
Dr. Joyce A. O'Shaughnessy from Baylor Sammons Cancer Center on Avastin as Her Standard of Care
Dr. Karen Reckamp from City of Hope Cancer center Discusses Heat Shock Proteins in Lung Cancer
Dr. Debu Tripathy from USC Norris Cancer Center Describes the Benefits of the PER Conferences
Dr. Antonio C. Wolff from Sidney Kimmel Comprehensive Cancer Center Discusses the Importance of HER2 Testing
Dr. Debu Tripathy from USC Norris Cancer Center on the Oncotype DX Assay Recurrence Score
Dr. Joyce A. O'Shaughnessy from Baylor Sammons Cancer Center on Continued Access to Avastin
Dr. Debu Tripathy from USC Norris Cancer Center Discusses Breast Cancer Gene Profiling
Dr. Debu Tripathy from the USC Norris Comphrensive Cancer Center Discusses Breast Cancer Biomarkers
Dr. Roy S. Herbst from Yale Comprehensive Cancer Center on Themes From the 2011 Lung Cancer Congress
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
4
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
5